Manifestation | Outpatients | Mixed non-severe | Non-severe inpatients | Severe non-ITU | Includes ITU | ||||||||||
Studies | Prevalence (95% CI) | I2 | Studies | Prevalence (95% CI) | I2 | Studies | Prevalence (95% CI) | I2 | Studies | Prevalence (95% CI) | I2 | Studies | Prevalence (95% CI) | I2 | |
Headache | 14 | 44.0 (32.8 to 55.8) | 96.7 | 20 | 41.9 (30.9 to 53.7) | 99.1 | 12 | 8.9 (3.5 to 20.8) | 97.9 | 16 | 12.1 (7.9 to 17.9) | 94.3 | 19 | 10.8 (7.1 to 16.2) | 96.7 |
Myalgia | 14 | 46.7 (36.8 to 56.8) | 95.7 | 19 | 40.9 (28.2 to 55.0) | 99.3 | 9 | 9.9 (3.6 to 24.4) | 98.6 | 13 | 11.3 (6.2 to 19.5) | 97.0 | 19 | 20.4 (14.7 to 27.6) | 97.9 |
Anosmia | 17 | 51.7 (42.2 to 61.1) | 97.1 | 22 | 51.2 (40.8 to 61.4) | 98.2 | 8 | 24.1 (8.2 to 53.1) | 98.0 | 8 | 35.9 (10.4 to 73.0) | 99.0 | 6 | 22.3 (11.0 to 40.1) | 95.2 |
Dysgeusia | 17 | 45.2 (34.1 to 56.8) | 98.0 | 14 | 50.2 (37.9 to 62.4) | 98.3 | 6 | 21.6 (10.6 to 39.2) | 95.3 | 7 | 25.3 (10.5 to 49.5) | 97.9 | 6 | 17.3 (7.8 to 33.8) | 94.8 |
Fatigue | 10 | 55.1 (43.3 to 66.3) | 97.8 | 13 | 42.2 (29.3 to 56.3) | 98.1 | 10 | 30.7 (16.7 to 49.4) | 98.0 | 16 | 24.0 (15.9 to 34.4) | 97.3 | 15 | 44.3 (31.5 to 58.0) | 99.1 |
ITU, intensive therapy unit.